Risk Prediction Using Polygenic Risk Scores for Prevention of Stroke and Other Cardiovascular Diseases. Issue 9 (17th August 2021)

• Record Type: Journal Article
• Authors: Abraham, Gad; Rutten-Jacobs, Loes; Inouye, Michael
• Is Part Of: Stroke. Volume 52:Issue 9(2021)
• Page Start: 2983
• Page End: 2991
• Publication Date: 2021-08-17
• Subjects: cardiovascular disease -- genetics -- myocardial infarction -- risk assessment -- stroke; Cerebrovascular disease -- Periodicals; Cerebral circulation -- Periodicals; 616.81
• DOI: 10.1161/STROKEAHA.120.032619
• Languages: English
• ISSNs: 0039-2499

Abstract

Abstract : Early prediction of risk of cardiovascular disease (CVD), including stroke, is a cornerstone of disease prevention. Clinical risk scores have been widely used for predicting CVD risk from known risk factors. Most CVDs have a substantial genetic component, which also has been confirmed for stroke in recent gene discovery efforts. However, the role of genetics in prediction of risk of CVD, including stroke, has been limited to testing for highly penetrant monogenic disorders. In contrast, the importance of polygenic variation, the aggregated effect of many common genetic variants across the genome with individually small effects, has become more apparent in the last 5 to 10 years, and powerful polygenic risk scores for CVD have been developed. Here we review the current state of the field of polygenic risk scores for CVD including stroke, and their potential to improve CVD risk prediction. We present findings and lessons from diseases such as coronary artery disease as these will likely be useful to inform future research in stroke polygenic risk prediction.